BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18779564)

  • 1. TGF-beta and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3.
    Samanta A; Li B; Song X; Bembas K; Zhang G; Katsumata M; Saouaf SJ; Wang Q; Hancock WW; Shen Y; Greene MI
    Proc Natl Acad Sci U S A; 2008 Sep; 105(37):14023-7. PubMed ID: 18779564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy between IL-6 and TGF-β signaling promotes FOXP3 degradation.
    Gao Z; Gao Y; Li Z; Chen Z; Lu D; Tsun A; Li B
    Int J Clin Exp Pathol; 2012; 5(7):626-33. PubMed ID: 22977658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT6 Inhibits TGF-beta1-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor.
    Takaki H; Ichiyama K; Koga K; Chinen T; Takaesu G; Sugiyama Y; Kato S; Yoshimura A; Kobayashi T
    J Biol Chem; 2008 May; 283(22):14955-62. PubMed ID: 18400747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JunB and c-Rel cooperatively enhance Foxp3 expression during induced regulatory T cell differentiation.
    Son JS; Sahoo A; Chae CS; Hwang JS; Park ZY; Im SH
    Biochem Biophys Res Commun; 2011 Apr; 407(1):141-7. PubMed ID: 21371435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo.
    Chen Q; Kim YC; Laurence A; Punkosdy GA; Shevach EM
    J Immunol; 2011 Jun; 186(11):6329-37. PubMed ID: 21525380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7.
    Fantini MC; Becker C; Monteleone G; Pallone F; Galle PR; Neurath MF
    J Immunol; 2004 May; 172(9):5149-53. PubMed ID: 15100250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranuclear interactomic inhibition of FoxP3 suppresses functions of Treg cells.
    Park JH; Ko JS; Shin Y; Cho JY; Oh HA; Bothwell AL; Lee SK
    Biochem Biophys Res Commun; 2014 Aug; 451(1):1-7. PubMed ID: 25044110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical Role of TGF-β and IL-2 Receptor Signaling in Foxp3 Induction by an Inhibitor of DNA Methylation.
    Freudenberg K; Lindner N; Dohnke S; Garbe AI; Schallenberg S; Kretschmer K
    Front Immunol; 2018; 9():125. PubMed ID: 29456534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cellular MicroRNA Facilitates Regulatory T Lymphocyte Development by Targeting the
    Zhang Y; Liu W; Chen Y; Liu J; Wu K; Su L; Zhang W; Jiang Y; Zhang X; Zhang Y; Liu C; Tao L; Liu B; Zhang H
    J Immunol; 2018 Feb; 200(3):1053-1063. PubMed ID: 29282311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous TGF-beta activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4+CD25- T cells.
    Amarnath S; Dong L; Li J; Wu Y; Chen W
    Retrovirology; 2007 Aug; 4():57. PubMed ID: 17688698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
    Prochazkova J; Pokorna K; Holan V
    Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN regulatory factor-1 negatively regulates CD4+ CD25+ regulatory T cell differentiation by repressing Foxp3 expression.
    Fragale A; Gabriele L; Stellacci E; Borghi P; Perrotti E; Ilari R; Lanciotti A; Remoli AL; Venditti M; Belardelli F; Battistini A
    J Immunol; 2008 Aug; 181(3):1673-82. PubMed ID: 18641303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.
    Zhou L; Lopes JE; Chong MM; Ivanov II; Min R; Victora GD; Shen Y; Du J; Rubtsov YP; Rudensky AY; Ziegler SF; Littman DR
    Nature; 2008 May; 453(7192):236-40. PubMed ID: 18368049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice.
    Carrier Y; Yuan J; Kuchroo VK; Weiner HL
    J Immunol; 2007 Jan; 178(1):179-85. PubMed ID: 17182553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor α and γ agonists together with TGF-β convert human CD4+CD25- T cells into functional Foxp3+ regulatory T cells.
    Lei J; Hasegawa H; Matsumoto T; Yasukawa M
    J Immunol; 2010 Dec; 185(12):7186-98. PubMed ID: 21057085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen-Rich Saline Ameliorates Allergic Rhinitis by Reversing the Imbalance of Th1/Th2 and Up-Regulation of CD4+CD25+Foxp3+Regulatory T Cells, Interleukin-10, and Membrane-Bound Transforming Growth Factor-β in Guinea Pigs.
    Xu F; Yu S; Qin M; Mao Y; Jin L; Che N; Liu S; Ge R
    Inflammation; 2018 Feb; 41(1):81-92. PubMed ID: 28894978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling.
    Oberle N; Eberhardt N; Falk CS; Krammer PH; Suri-Payer E
    J Immunol; 2007 Sep; 179(6):3578-87. PubMed ID: 17785792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IκB(NS) protein mediates regulatory T cell development via induction of the Foxp3 transcription factor.
    Schuster M; Glauben R; Plaza-Sirvent C; Schreiber L; Annemann M; Floess S; Kühl AA; Clayton LK; Sparwasser T; Schulze-Osthoff K; Pfeffer K; Huehn J; Siegmund B; Schmitz I
    Immunity; 2012 Dec; 37(6):998-1008. PubMed ID: 23200824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.